Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acotec Scientific HoldingsHKSE:06669 +1.49%72 PE Ratio (TTM) is 14.40 as of Sep. 17, 2026, which is 74% below its 10-year median of 55.41. GuruFocus rates HKSE:06669 with a GF Score™ of 72/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 440 Medical Devices & Instruments companies, Acotec Scientific Holdings ranks better than 75.45% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-09-17), Acotec Scientific Holdings's share price is
HK$6.15.
Acotec Scientific Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.43. Therefore, Acotec Scientific Holdings's PE Ratio (TTM) for today is 14.40.
Good Sign:
Acotec Scientific Holdings Ltd stock PE Ratio (=13.54) is close to 5-year low of 13.54.
The historical rank and industry rank for Acotec Scientific Holdings's PE Ratio (TTM) or its related term are showing as below:
HKSE:06669'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss Med: 55.41 Max: 195.27
Current: 14.4
During the past 7 years, the highest PE Ratio (TTM) of Acotec Scientific Holdings was 195.27. The lowest was 0.00. And the median was 55.41.
HKSE:06669's PE Ratio (TTM) is ranked better than 75.45% of 440
companies
in the Medical Devices & Instruments industry
Industry Median: 24.015
vs HKSE:06669: 14.40
During the past 7 years, Acotec Scientific Holdings's highest 3-Year average EPS without NRI Growth Rate was 49.00% per year. The lowest was 13.90% per year. And the median was 31.45% per year.
Acotec Scientific Holdings (HKSE:06669) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Acotec Scientific Holdings PE Ratio (TTM) Related Terms
Acotec Scientific Holdings PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06669 vs ABT, SYK, MDT: PE Ratio (TTM) Comparison
For the Medical Devices subindustry, Acotec Scientific Holdings's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's PE Ratio (TTM) falls into.
Acotec Scientific Holdings PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Acotec Scientific Holdings's Share Price of today is HK$6.15.
For company reported semi-annually, Acotec Scientific Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Acotec Scientific Holdings (HKSE:06669) has a PE Ratio (TTM) of 14.40 as of Sep. 17, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Acotec Scientific Holdings and its competitors. This is 74% below median its historical median of 55.41. According to the industry distribution chart, Acotec Scientific Holdings ranks #108 out of 440 companies in the Medical Devices & Instruments industry, placing it in the top 24.5%.
Is Acotec Scientific Holdings' PE Ratio (TTM) too high?
Acotec Scientific Holdings' current PE Ratio (TTM) of 14.40 is 74% below median its 10-year median of 55.41. The Medical Devices & Instruments industry median PE Ratio (TTM) is 24.02. Acotec Scientific Holdings' value of 14.40 is 40% below this industry median. Based on the distribution chart, Acotec Scientific Holdings ranks #108 out of 440 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Acotec Scientific Holdings has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' PE Ratio (TTM) compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Acotec Scientific Holdings ranks #108 out of 440 companies for PE Ratio (TTM). This places Acotec Scientific Holdings in the top 25% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 24.02. Acotec Scientific Holdings' value of 14.40 is 40% below this benchmark. While the company's 10-year median is 55.41 vs. the industry median of 24.02, Acotec Scientific Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 24.02, based on 440 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acotec Scientific Holdings's current PE Ratio (TTM) of 14.40 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Acotec Scientific Holdings and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 24.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acotec Scientific Holdings's current PE Ratio (TTM) is 14.40, which is 74% below median its own 10-year median of 55.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$6.15 — trading 58.9% below its estimated fair value. The current PE Ratio (TTM) is 14.40, which is 74% below median its 10-year median of 55.41 and 40% below the Medical Devices & Instruments industry median of 24.02. Acotec Scientific Holdings' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current PE Ratio (TTM) is 14.40 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?
Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued.
The current stock price of HK$6.15 is trading 58.9% below its estimated GF Value™ of HK$14.95.
GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:06669:
PE Ratio (TTM): 14.40 (74% below median its 10-year median of 55.41)
GF Value™: HK$14.95 vs. price of HK$6.15 (58.9% below fair value)
Industry Position: 40% below the Medical Devices & Instruments median (#108 of 440)
No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
72GF Score
Get the complete analysis for HKSE:06669
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06669 has been successfully added to your 
